China-US Event to Focus on China's Crackdown Against Foreign Pharmaceutical Firms

WASHINGTON, July 17, 2013 /PRNewswire-USNewswire/ -- The Chinese government is taking a hard line against pharmaceutical companies that violate anti-bribery laws, as seen by the recent actions taken against multinational firms. But this tough enforcement — in what is projected to be the second largest pharmaceutical market in the world — is not limited to only the drug industry. The Food and Drug Law Institute's China-US Updates in Food and Drug Law conference being held in Beijing on October 15-16 will address recent enforcement actions against pharmaceutical, medical device and food companies both in China and the US, focusing on the Foreign Corrupt Practices Act (FCPA), anti-bribery actions and stricter penalties. Learn more.  



Contact: Erin Jones, VP, Marketing,, 202-222-0899

SOURCE Food and Drug Law Institute


More by this Source

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.